Patients with T2DM have an increased risk of CVD. Prevention of CVD represents the major goal of all treatment of T2DM, and early intervention in those patients at particularly high risk is important. We measured the insulin sensitivity and plasma biomarkers of CVD to determine whether a home-based exercise training program improves biomarker levels and insulin sensitivity. Patients with T2DM (n=12), IGT (n=4) and healthy control subjects (n=9) were studied before and after eight weeks of exercise training by rowing ergometry at 65-70% of peak oxygen uptake. Conclusions: 1) patients with T2DM have elevated plasma concentrations of CVD biomarkers compared to the matched control and IGT groups; 2) a moderate to vigorous intensity home-based training program did not reduce plasma concentrations of these CVD markers; 3) insulin sensitivity improved as a result of exercise training in the control group, but not in the T2DM group.
Introduction
Patients with T2DM mellitus have a high risk of developing CVD with a diminished survival rate compared with nondiabetes patients, making the prevention of CVD in patients with T2DM essential.
The identification of patients who are at particular risk for future CVD events represents a strategy towards targeted prevention. Screening by means of blood-borne biomarkers that are associated with CVD, such as CRP adhesion molecules (VCAM-1 and ICAM-1) and vWf, may serve this purpose. Increased blood concentrations of the soluble forms of the adhesion molecules and the other biomarkers have been associated with CVD and have also been reported to be increased in T2DM, 1 although the results vary according to the specific marker investigated.
Exercise training improves insulin sensitivity and prevents CVD, but the effect of physical training on forearm endothelial function, 2,3 and on CVD biomarkers in patients with obesity and/or T2DM has yielded conflicting results. 4, 5 We have now determined whether an eight week homebased exercise training program would improve CVD biomarkers in patients with T2DM.
Methods
Twelve male patients with T2DM and nine male healthy control subjects participated in this study. The control subjects had normal glucose tolerance, which was determined by an OGTT. Two patients with T2DM were treated with diet alone, five patients were treated with metformin, and five patients were treated with metformin plus sulfonylurea as glucose lowering therapy. With the exception of medicallycontrolled hypertension (n=2; one patient was treated by an ACE inhibitor and one patient was treated by a beta blocker) and hypercholesterolemia (n=1; patient treated by statins) in T2DM patients, none of the subjects had any sign or history of overt CVD. In addition, three patients were prescribed statins plus ACE inhibitors by their general practitioner for preventative measures. Twenty-four hours before the experiment, all pharmacological treatment was suspended. One patient with T2DM and two healthy subjects in the control group were smokers. The two groups were matched for age, body weight and percentage of body fat. We also included an additional small group of subjects with IGT (n=4; as determined by an OGTT; 2 h plasma glucose concentration =10.1±1.6 mmol/L), who were otherwise healthy. One IGT subject was a smoker. The characteristics are shown in Table 1 .
The study protocol was approved by the ethical committee of Copenhagen and Frederiksberg (01-069/02). The data presented in this manuscript are part of a larger study on the influence of physical activity on glucose homeostasis and the regulation of peripheral blood flow at rest and during exercise.
All subjects performed a sub maximal rowing ergo meter test at 40, 60 and 80 W for 4 minutes each. HRs were recorded and capillary blood lactate concentrations were measured at the end of each step. Following this, the maximal HR and oxygen uptake were measured (VO 2 peak ) during a stepwise maximal exercise test on a stationary bicycle until exhaustion. Body composition was measured by DEXA.
The subjects were studied after an overnight fast (12 h, water permitted). After the insertion of two venous and one arterial catheter and baseline measurements, all subjects underwent a 180 m hyperinsulinemic, isoglycemic glucose clamp. Insulin was infused intravenously (2 pmol/(m kg)). The whole body insulin action was calculated as the glucose infusion rate during the final 30 m of the clamp divided by the plasma glucose concentration, and thus expressed as glucose clearance rates (ml/(m (kg body weight))).
ET-1, VCAM-1 and ICAM-1 were measured by ELISA immunoassays from R&D systems (Abingdon, Oxon, UK). CRP was analysed with a high-sensitivity assay (Roche Diagnostics, Mannheim, Germany). Homocysteine was measured with reagent Axis-Shield Enzymatic Homocysteine FHER100 on a Thermo Konelab 30i. The vWf antigen was measured with an in-house ELISA technique using polyclonal rabbit anti-human vWf antibodies for capture and polyclonal rabbit anti-human vWf antibodies for detection.
The exercise program consisted of eight weeks of rowing on a home rowing ergo meter (30 m every other day for a total of 28 sessions). The subjects were instructed to maintain a specified HR by means of a HR monitor (Polar, Finland) corresponding to a work rate of 65-70% of peak VO 2 as determined from the pre-training maximal exercise test, and they kept a training diary confirming adherence, which was 100%.
Statistics
The results are presented as means ± SE unless otherwise stated. Differences were analysed by ANOVA for 
Results

Body composition, fitness and metabolism parameters
Weight, BMI, body fat, blood pressure, HbA 1C , and glucose and insulin concentrations did not change with exercise training (data not shown). Before the training intervention, the T2DM subjects had a lower (P<0.05) VO 2peak compared with the control subjects (25.0±1.2 and 32.9±2.3 ml/(m kg), respectively) and IGT subjects (29.5±2.4 ml/(m kg)), but VO 2peak was not increased after the intervention (24.6±1.6, 32.7±1.5 and 24.6±3.4 ml/(m kg) in the three groups, respectively).
In the T2DM and control subjects, training improved fitness as seen by blood lactate concentrations and HRs during sub maximal exercise testing (data not shown). In the IGT subjects there were no significant changes due to training (data not shown).
Plasma insulin, glucose concentrations and HbA 1C were higher in the T2DM subjects compared with the control and IGT subjects ( Table 1 ). The whole body insulin action was always higher in the control versus the T2DM subjects (P<0.05), but was similar to that in the IGT subjects (P>0.05) and improved in the control subjects with training (2.16±0.32 versus 2.74±0.28 ml/(m (kg body weight)) (P<0.05)), but in the T2DM (0.95±0.12 versus 1.17±0.17 ml/(m (kg body weight))) and IGT subjects (2.41±0.32 versus 2.22±0.54 ml/ (m (kg body weight))) no significant change was observed. Plasma insulin concentrations at the end of the clamps were higher (P<0.05) in the T2DM subjects (237±23 and 272±27 pmol/L; pre-and post-intervention, respectively) compared with the control subjects (158±17 and 181±11 pmol/L; preand post-intervention, respectively). The plasma insulin concentration during the clamps in the IGT subjects did not differ from the T2DM or control subjects (207±23 and 195±18 pmol/L; pre-and post-intervention, respectively).
CVD biomarkers
Plasma concentrations of ICAM-1 and VCAM-1 were higher (P<0.05) in the T2DM subjects compared with the control subjects and exercise training had no effect on the concentrations in either group (Figure 1) .
Plasma concentrations of ET-1 were at pretraining significantly (P<0.05) increased in the T2DM and IGT subjects, compared with the control subjects. Due to a (non-significant) increase with training in ET-1 concentrations in the control subjects, a significant difference between the groups could not be detected post training (Figure 1 ). CRP was did not differ between the groups, and in the T2DM subjects there was a significant (P=0.04) decrease with training ( Figure 1) . The vWf was always higher (P<0.05) in the T2DM subjects compared with the control subjects, and training had no effect (Figure 1) . Homocysteine was not different between the groups and did not change with training (Figure 1 ).
Discussion
The main findings of the present study are 1) that patients with T2DM have elevated concentrations of plasma CVD biomarkers (i.e. soluble adhesion molecules, ET-1 and vWf) compared with matched subjects with IGT and control subjects and 2) an eight week moderate to vigorous intensity home-based training program is not sufficient to reduce plasma concentrations of these CVD markers.
There is no consensus as to which plasma markers of CVD and to what degree they are affected by the diabetic or pre diabetic state. Our finding of increased plasma concentrations of the VCAM-1 and the ICAM-1 in subjects with T2DM is in line with most, but not all, previous studies. 1, [6] [7] [8] [9] [10] [11] Increased plasma concentrations of ET-1, 9, 11 and of the vWf 9,10 in T2DM subjects are more consistent findings and the present study supports this. The clear effect of T2DM on the soluble adhesion molecules (ICAM-1 and VCAM-1) is supported by the majority of the past studies, although due to the wide variety of confounding factors (e.g. hypertension, microalbuminuria, weight), it is difficult to conclude whether the previously reported differences are due to diabetes per se, or are a result of concurrent risk factors for CVD. Thus, in the present study, the close matching of subjects (except that the controls were taller) confirms that the differences in plasma-soluble adhesion molecules can be attributed to the diabetic state.
Low-grade inflammation plays an important major role in atherosclerosis, and CRP is a strong predictor of future coronary heart disease. In contrast to previous studies of a slightly larger scale (n=26-30) that included men and women, 7,12 CRP concentrations were similar in the T2DM and control subjects. Elevated CRP concentrations have been accompanied by endothelial dysfunction in one study, 12 but not in another. 7 The latter finding is in accordance with the present study, in which a subgroup of control subjects (n=8) and T2DM subjects (n=10) had endothelialdependent vasodilatation measured as forearm blood flow in response to intra-arterial infusion of acetylcholine (60 µg/m), with similar blood flow in the two groups (12.8±2.0 and 9.2±2.1 ml/m 100 ml, respectively). Thus, a strong association between markers of inflammation and endothelial dysfunction may not always be present. Having elevated plasma concentrations of homocysteine is an established risk factor for CVD and it has been found to be elevated in T2DM. 13 Consistent with our findings of similar endothelial function in control and T2DM subjects, we found that homocysteine concentrations did not differ between the two groups.
CVD biomarkers were also measured during hyperinsulinemia (clamp), and a significant decrease was found for the ICAM-1 and ET-1 concentration in the T2DM and control subjects (data not shown).
An eight week home-based training program, at an intensity of 65-70% of maximum HR, was insufficient to generally reduce biomarkers of CVD. The main intention behind this program design was to assess an exercise training regime that was 'user friendly', easy to perform within the subjects' personal schedules and with a protocol that would motivate subjects to continue regular physical activity. While there were fitness benefits from this program for all subjects, seen at sub maximal intensities, VO 2Peak did not increase in any of the groups and improved insulin sensitivity could only be demonstrated in the control group. For the biomarkers included in this study, it is most likely that a higher stimulus (intensity and/or frequency of exercise sessions) or a longer training period is required.
Past studies employing a more intense exercise regime did find a decrease in plasma adhesion molecules (ICAM-1, VCAM-1) in their populations with impaired glucose metabolism, but not in their controls. 4, 14 The training protocol in the latter studies was considerably more intense, and it is questionable whether this type of program is feasible on a long-term basis.
In young obese subjects with and without concurrent early onset T2DM, concentrations of plasma adhesion molecules did not change with training in either group, despite varying fitness response: 24% increase in VO 2 max in the non-diabetic control group and no change in the diabetes group. 5 The lack of change in VO 2 max and in CVD markers in patients with T2DM is similar to what is presented here.
A limited number of subjects (and only men) were studied. However, pre-study power calculations (based on literature values that were available) indicated that the potential effects of training and the differences between groups would have been detected with a power of 0.60-0.85 (depending on the parameter in question). Further, a possible confounder was diet, which was not controlled. No weight loss accompanied the training program, which means that daily energy intake was increased.
